14 advisor opinions Base Subscription Required
Northrop Grumman AI Forecast Summary
Unlock the rating distributions, return ranges and advisor comparison with a Base subscription.
Checking your access...
Browse Free Assets1 Year Ratings & Returns ()
Ratings: 6 Neutral 6 Buy 2 Strong Buy
Returns range: from +1.9% to +11.4%
5 Year Ratings & Returns ()
Ratings: 12 Buy 2 Strong Buy
Returns range: from +34.4% to +78.6%
Calculated from End of Date $548.61
What do advisors disagree on
The central disagreement across research reports concerns the timing of free cash flow liberation and capital return resumption. Bullish perspectives argue that capital expenditure peaked in 2023 at 4.5% and has already receded toward 3.5%, expecting immediate double-digit cash flow compounding and aggressive share repurchases. Conversely, grounded forensic analyses cite primary management guidance projecting elevated capex near 4.5% through 2028 to build out bomber and rocket motor capacity, during which share repurchases have been halted. This debate will be resolved by monitoring reported quarterly capex levels and cash conversion metrics over the next four quarters.
Compare all 14 opinions1 Year & 5 Year ratings, targets & returns · Sorted by 5 Year price return
| Advisor | Model | Research | 1 Year | 5 Year | Full Report | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target date | Rating | Price target | Price return | Return incl. dividends | Target date | Rating | Price target | Price return | Return incl. dividends | ||||
| J.P. Morgan AI The Titan Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $610.98 | +11.4% | +12.5% | $979.80 | +78.6% | +89.4% | Full report | ||||
| Warren Buffett AI The Value Seeker Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $599.29 | +9.2% | +10.4% | $970.47 | +76.9% | +87.6% | Full report | ||||
| Sherlock Holmes AI The Whistleblower Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $610.98 | +11.4% | +12.5% | $897.77 | +63.6% | +73.6% | Full report | ||||
| Superintelligence AI The Anthropologist Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $593.53 | +8.2% | +9.3% | $889.48 | +62.1% | +72.0% | Full report | ||||
| Niccolo Machiavelli AI The Insider Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $587.76 | +7.1% | +8.3% | $871.96 | +58.9% | +68.6% | Full report | ||||
| Warren Buffett AI The Value Seeker Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $582.11 | +6.1% | +7.2% | $830.76 | +51.4% | +60.6% | Full report | ||||
| Superintelligence AI The Anthropologist Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $582.00 | +6.1% | +7.2% | $821.50 | +49.7% | +58.8% | Full report | ||||
| Ray Dalio AI The Strategist Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $576.41 | +5.1% | +6.2% | $814.39 | +48.4% | +57.4% | Full report | ||||
| Universal Investor AI The Polymath Framework | Claude Opus 5 | Researcher Mode with Web Search Used | $575.39 | +4.9% | +6.0% | $809.92 | +47.6% | +56.6% | Full report | ||||
| Universal Investor AI The Polymath Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $570.81 | +4.0% | +5.1% | $806.09 | +46.9% | +55.8% | Full report | ||||
| Universal Investor AI The Polymath Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $570.81 | +4.0% | +5.1% | $790.98 | +44.2% | +52.9% | Full report | ||||
| Michael Burry AI The Vulture Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $582.00 | +6.1% | +7.2% | $790.83 | +44.2% | +52.9% | Full report | ||||
| Universal Investor AI The Polymath Framework | GPT-6 Astra | Researcher Mode with Web Search Used | $558.95 | +1.9% | +2.9% | $750.57 | +36.8% | +45.1% | Full report | ||||
| Elon Musk AI The Visionary Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $576.41 | +5.1% | +6.2% | $737.54 | +34.4% | +42.6% | Full report | ||||
Prices, dates & return assumptions
1 Year and 5 Year identify the original published checkpoints. Current returns compare the dated close with each fixed target over its remaining horizon. Original quarterly tables use the publication-time anchor. Targets and observed prices share a split-adjusted basis.
Ratings use the shared volatility-adjusted calculation.
Dividend returns model a 1.22% annual net yield, reinvested over the remaining time to target.
Ranges and rating distributions use matching currencies, price bases and target dates. Missing or expired checkpoints are excluded; targets are never extrapolated. Shared frameworks and models can produce correlated opinions.
Northrop Grumman Stock Analysis & Forecast — Universal Investor The Polymath Framework on Claude Opus 5 Model
Universal Investor AI · The Polymath Framework
5 Year Rating
5 Year Price Return
+47.6%
Incl. net dividends
+56.6%
Framework Description & Key Record Dates
Investment Framework
The Polymath Framework: Eight-Lens Investment Analysis Framework
Analysis Framework Description: Select the lenses with the greatest explanatory power, resolve their disagreements across horizons, and connect the evidence to a consistent thesis, scenario path, and verdict.
- Ownership and value: examine economic rights, competitive advantage, capital allocation, and the price paid.
- Regimes and constraints: connect credit, liquidity, policy, demand, and physical bottlenecks to the asset.
- Innovation and adaptation: test adoption economics, AI and robotics exposure, substitution, and value capture.
- Forensics and incentives: reconcile accounting, cash conversion, dilution, governance, and missing evidence.
- Expectations and reflexivity: distinguish changes in fundamentals from changes in narratives and valuation.
- Probabilities and resilience: use base rates, competing scenarios, catalysts, and the capacity to survive the wait.
- Power and the rules of the game: assess political interests, regulatory influence, protection, and dependency.
- Industry structure and consolidation: identify pricing power, chokepoints, alliances, and the economics of integration.
- Model Producer:
- Anthropic
- Model Version:
- Claude Opus 5
- Mode Used:
- Researcher
- Input Data:
- Input records not available
- Forecast Target Date:
- Latest Known Price Date for Return Estimate Refresh:
- Forecast Published On:
- Forecast Generated On:
- Model knowledge cutoff:
- Supplied Context Data, Prices & Events Cutoff:
- Not recorded
Return calculation details
Current returns use the observed price and remaining time to the fixed published target. The quarterly table retains the original forecast anchor. Dividend-inclusive returns assume 1.22% annual net yield, reinvested until the target.
Full advisor report Chart, analysis, and sources
Northrop Grumman: Historical Prices & Published Forecast
Analyzed by The Polymath Framework using the Opus 5 model
- Observed price
- Published advisor forecast
Northrop Grumman: Quarterly Price Forecasts & Scenarios
Analyzed by The Polymath Framework using the Opus 5 model
Price targets, price returns and complete scenario reasoning
Forecast prices in USD. Price returns are cumulative from the original forecast anchor dated 2026-09-18; they exclude dividends. Swipe horizontally to read every column.
| Quarter | Forecast | Price return | Scenario |
|---|---|---|---|
| $554 | +5.0% | Q3 results and the year-end B-21 rate-and-fleet analysis conclusion draw buyers back to an oversold prime near 52-week lows; the $4.84B CIRCM award anchors 2027 revenue visibility and supports partial recovery. | |
| $576 | +9.2% | FY2026 results confirm book-to-bill above 1.25x and backlog above $105B. Initial 2027 guidance frames the production-phase margin inflection, drawing value capital despite the 10Y still holding near 5%. | |
| $593 | +12.5% | First operational B-21 fielding at Ellsworth and the Sentinel test-launch milestone provide programmatic validation. Enacted FY2027 appropriations clarify how much of the reconciliation tranche survives Senate negotiation. | |
| $575 | +9.1% | Consolidation quarter. A renewed negative EAC adjustment on Space or fixed-price weapons programs revives margin skepticism, while continuing-resolution friction delays new-start award conversion into recognized revenue. | |
| $604 | +14.6% | With the Fed cycle turning and long yields easing from the 5% peak, discount-rate pressure reverses. Sentinel restructure clarity and improving Defense Systems margin justify multiple repair toward 19x forward. | |
| $622 | +18.0% | FY2027 results show operating margin recovering above 10.5% as low-rate B-21 lots retire. Management signals buyback resumption as capex approaches its crest, restoring the per-share growth channel. | |
| $635 | +20.4% | Steady compounding without catalyst. International orders build toward the $10B target, but investors await evidence that fixed-price European contracts carry the margin premium management implies. | |
| $609 | +15.5% | US election-cycle uncertainty over defense toplines and any credible de-escalation in the Gulf compress defense multiples sector-wide. Northrop's nuclear concentration amplifies headline sensitivity despite contracted backlog. | |
| $640 | +21.3% | Post-election clarity removes the budget overhang. Triad recapitalization survives intact across administrations, and capex crossing its peak frees cash for resumed repurchases, restoring the per-share accretion narrative. | |
| $659 | +25.0% | FY2028 results demonstrate adjusted EPS above $38 with free cash flow exceeding $4B. Higher B-21 delivery rate finally shows operating leverage rather than expansion cost in reported segment margin. | |
| $679 | +28.7% | Golden Dome architecture contracts convert to recognized revenue, diversifying an order book previously concentrated in two nuclear programs. Sensor and interceptor work carries better margin rate than cost-type development. | |
| $692 | +31.3% | Modest advance as normalized rates support the multiple. Sentinel approaches early-2030s capability milestones without further cost breach, gradually removing the program-risk discount embedded since 2024. | |
| $713 | +35.2% | Year-end repositioning favours cash-generative industrials with contracted revenue. Buyback run-rate returning toward $1.5B annually shrinks share count again, adding roughly one point to annual EPS growth. | |
| $727 | +37.9% | FY2029 results confirm mid-single-digit revenue compounding and margins near 11%. Valuation support comes from earnings delivery rather than re-rating, limiting the quarter's advance to incremental progress. | |
| $706 | +33.8% | Late-cycle profit-taking in defense as the post-2026 rearmament wave matures and European procurement growth decelerates. International order intake falls short of the doubling trajectory in one reporting period. | |
| $727 | +37.8% | Recovery as B-21 reaches full-rate production economics and the next-generation bomber franchise begins generating the sustainment revenue stream that historically carries the highest margin for primes. | |
| $756 | +43.3% | Free cash flow conversion improves materially with capex normalized post-expansion. The market reprices Northrop on cash returns rather than backlog optics, supporting a higher free-cash-flow-based valuation. | |
| $771 | +46.2% | FY2030 results validate the multi-year thesis: revenue near $58B, adjusted EPS in the mid-$40s. Incremental gains as expectations have largely caught up with delivered operating performance. | |
| $794 | +50.6% | The 2031 international target of $10B annual sales comes into view, testing management's five-year commitment. Partial achievement still improves mix toward fixed-price work with superior margin rate. | |
| $810 | +53.6% | Horizon close with Northrop compounding steadily. Sentinel production and B-21 sustainment underpin the next decade, while the multiple settles near 17-18x — no re-rating assumed beyond earnings delivery. |
Show remaining 18 quartersShow first 2 quarters only
All 20 quarters are displayed in the table above.
Northrop Grumman: Investment Thesis Base Case
Analyzed by The Polymath Framework using the Opus 5 modelThe central tension is that Northrop's order book compounds faster than its cash returns. A $104,692M backlog at June 30, 2026 and guided book-to-bill above 1.25x lock in revenue into the 2030s , but Sentinel's cost-type restructure and a self-funded capacity build convert political demand into low-margin volume while repurchases have stopped entirely. The base case resolves this slowly rather than dramatically: revenue compounds mid-single digits, operating margin repairs toward 11% as low-rate lots retire, and buybacks resume once capex crests around 2028. Investors are paid through earnings growth, not multiple expansion.
- TTM revenue $42.9B and FCF $3.65B; mid-single-digit growth with margin repair lifts cash materially.
- At ~18x guided 2026 adjusted EPS of $28.85, stable multiples plus EPS compounding carry the price.
- Cross-check: ~$113B equity plus ~$15B net debt on ~$11B EBITDA equals ~11.6x, near today's 12x.
Northrop Grumman: Scenarios & Signals
Analyzed by The Polymath Framework using the Opus 5 modelBull Case
Everything hinges on one word: rate. If the Air Force formalises a larger B-21 program of record and a faster production rate during 2027, the already-funded capacity expansion fills with fixed-price-incentive work at improving margin, EAC charges disappear from the narrative, and free cash flow overshoots guidance. Add an F/A-XX win and international sales reaching the $10B target, and Northrop re-rates from nuclear-utility to growth-prime multiple while resuming meaningful repurchases. Price approaches $1,100.
Bear Case
The trap is a company that books orders it cannot profit from. Should the Sentinel rebaseline arrive descoped, fixed-price inflation trigger fresh forward losses, and the $350B reconciliation tranche fail in Congress, revenue grows while margin stagnates near 9%, free cash flow undershoots $3B, and the buyback stays dark. A defense prime with no per-share accretion and a 5% competing risk-free rate is simply a bond with execution risk; the multiple compresses toward 13x and shares revisit the low $400s.
Behavioral Alpha Signals
Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.Expected Volatility Regime: Moderate
Greed and Fear Index: -28 / 100 (Fear)
Cycle Position: Stabilization
The reset is mostly complete and price drifts toward fair value.
What does Media Tell? (Crowd Consensus)
The crowd treats NOC as a broken defense supercycle trade: record backlog, but nobody gets paid. Consensus targets near $662 and a Guggenheim initiation at $612 sit 16-26% above a $527 tape — sell-side believes the story, the tape does not . The anchoring bias is February's ~$724 print ; investors now price margin skepticism and a 5% discount rate, not order books.
What Crowds Get Wrong? (Alpha/Value Gap)
The crowd modestly underestimates these shares. The market has correctly identified the margin problem and wrongly extrapolated it as permanent, because it cannot distinguish LRIP-phase EAC charges from steady-state economics. The overlooked evidence: the $4.5B capacity agreement and $2.5B self-funded expansion are the cost of a production-rate step-up whose revenue arrives after the spending . Buying a prime at ~18x guided adjusted EPS during its capex trough, not its cash-return peak, is where the asymmetry sits.
When will Value Gap Repricing Happen? (Repricing Catalyst)
The B-21 rate-and-fleet analysis concluding around end-2026, followed by the first clean production-lot quarter without a negative EAC adjustment. That combination proves the charges were phase-specific. The first observable sign: segment operating margin in Defense Systems recovering sequentially, with buyback resumption signalled.
How is Asset Influenced by Macro Regime?
Two channels dominate. The 10Y near 5% and the Fed at 3.75%-4.00% compress the multiple on a low-yield, long-duration cash-flow stream — a direct headwind. Offsetting it, the energy-security shock and Hormuz disruption keep defense appropriations politically protected. The thesis is far more sensitive to rate regime change than to GDP.
Northrop Grumman: Positive & Negative Factors, Risks & Opportunities
Analyzed by The Polymath Framework using the Opus 5 modelBase-Case Forces
Top Drivers / Tailwinds
Base-case positive forces
Structural or operating forces that support this advisor thesis. Base-case means above 70% probability of occurrence. Probabilities are model estimates; unquantified forces retain their published group.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Backlog Compounding INTO THE 2030s | Sector And Industry | +30% | +38% | The load-bearing evidence is the 10-Q: total backlog of $104,692M at June 30, 2026 versus $95,681M at year-end 2025, with Defense Systems up 25% on Sentinel awards . Management guides full-year book-to-bill above 1.25x . This converts into contracted revenue visibility through the early 2030s, underwriting mid-single-digit top-line compounding even if annual appropriations wobble. |
| Nuclear Triad IS Politically Untouchable | Political And Geopolitical | +22% | +25% | Northrop uniquely primes two legs of the recapitalized triad. The FY2027 request seeks roughly $445B (~44%) above FY2026 defense funding, with $6.1B earmarked to accelerate B-21 , and Congress already added $2.5B for Sentinel risk reduction . Sustained Iran/Hormuz and Pacific tension keeps deterrence spending insulated from fiscal retrenchment; this persists across the horizon because triad timelines outlast administrations. |
| LRIP PAIN Gives WAY TO Production Margin | Operational Efficiency | +18% | +22% | The deteriorating line is margin, not demand: Q2-2026 net income fell 6.8% on 5.1% revenue growth as B-21 low-rate lots and Space absorbed negative EAC adjustments . As LRIP lots retire and the $4.5B-funded 25% capacity expansion delivers rate , fixed-cost absorption improves. Recovering operating margin toward 11% on a larger revenue base is the single largest earnings lever in this forecast. |
| Europe AND ASIA Rearm Northrop Sells | Competitive Positioning | +12% | +14% | Management targets doubling annual international sales to roughly $10 billion by 2031 — a company objective, not booked orders, but directionally supported by European rearmament and Pacific missile-defense demand. International work typically carries firm-fixed-price economics and better margin rate than cost-type US development, so mix shift lifts consolidated profitability even at modest volume. The effect builds late in the horizon rather than immediately. |
Top Frictions / Headwinds
Base-case negative forces
Expected frictions that can slow, cap, or damage this advisor thesis. Base-case means above 70% probability of occurrence. Probabilities are model estimates; unquantified forces retain their published group.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Volume Bought WITH Margin RATE | Operational Efficiency | -16% | -18% | Sentinel's Nunn-McCurdy restructure, following an 81% cost growth and rescinded Milestone B , pushes work toward cost-type contracting that caps profit rate while protecting against loss. Combined with recurring EAC charges — a $157M unfavorable adjustment on the first four B-21 LRIP lots, plus a prior $477M charge — reported operating margin stays near 10% rather than the low-teens defense primes once earned. This drag persists until qualification completes. |
| FIVE Percent Discount RATE TWO Percent | Macroeconomic And Macrofinancial | -14% | -3.0% | The US 10Y closed at 4.998% on September 18 after the Fed's hike to 3.75%-4.00%, with median year-end projections at 4.1% for 2026 and 2027. A long-duration, ~1.9%-yielding industrial with decelerating buybacks is a direct casualty of a higher risk-free rate; much of the ~30% drawdown from February's ~$724 is de-rating, not impairment. The drag eases only when the tightening cycle turns. |
| Buybacks Sacrificed TO THE Factory | Capital Allocation | -12% | -9.0% | The forensic flag is stark: repurchases fell to $68M in Q1-2026 and zero in Q2-2026, against $1.62B in FY2025 and $2.51B in FY2024, while the company self-funds roughly $2.5B of B-21 capacity expansion . Share count stops shrinking, removing the 2-4% annual per-share tailwind that historically flattered EPS. Until capex peaks, earnings growth must be earned operationally, not engineered. |
| THE $350 Billion THAT DOES NOT Exist YET | Regulatory | -10% | -8.0% | About $350B of the headline FY2027 topline rides on a reconciliation bill that had not passed at the source date, and the discretionary increase needs bipartisan Senate support . Appropriators would also fund selected space programs below request and DOD proposed ending E-7A . Continuing resolutions delay new starts and slow award conversion, pushing revenue recognition right and compressing near-term cash generation. |
Risks & Opportunities
Top Risks / Downside Scenarios
Lower-probability downside scenarios outside the base-case forecast.
Unlock the risk analysis
Sign in with eligible access to read risks, opportunities and the remaining advisor reports.